Deutsche Bank AG Has $52.16 Million Stake in Revvity Inc. (NYSE:RVTY)

Key Points

• Deutsche Bank AG reduced its stake in Revvity Inc. by 10.5% in the first quarter, now owning approximately 0.41% of the company, valued at $52.16 million.
• Several institutional investors, including T. Rowe Price and EdgePoint Investment Group, increased their stakes in Revvity, with T. Rowe Price boosting its position by 16.7% in the fourth quarter.
• Revvity recently announced a quarterly dividend of $0.07 per share, equating to a 0.3% yield, with a payout ratio of 11.86%.

Deutsche Bank AG trimmed its holdings in shares of Revvity Inc. (NYSE:RVTY - Free Report) by 10.5% in the first quarter, according to its most recent filing with the SEC. The firm owned 492,995 shares of the company's stock after selling 57,619 shares during the period. Deutsche Bank AG owned approximately 0.41% of Revvity worth $52,159,000 as of its most recent filing with the SEC.

Other institutional investors have also made changes to their positions in the company. Wellington Management Group LLP boosted its position in Revvity by 13.2% in the fourth quarter. Wellington Management Group LLP now owns 6,655 shares of the company's stock valued at $743,000 after buying an additional 776 shares in the last quarter. Russell Investments Group Ltd. boosted its holdings in shares of Revvity by 11.2% in the 4th quarter. Russell Investments Group Ltd. now owns 46,387 shares of the company's stock worth $5,172,000 after acquiring an additional 4,661 shares in the last quarter. Bank of Nova Scotia grew its position in Revvity by 3.3% during the 4th quarter. Bank of Nova Scotia now owns 16,295 shares of the company's stock worth $1,819,000 after acquiring an additional 513 shares during the last quarter. Raymond James Financial Inc. acquired a new stake in Revvity during the 4th quarter valued at $2,248,000. Finally, Sterling Capital Management LLC increased its holdings in Revvity by 19.1% during the 4th quarter. Sterling Capital Management LLC now owns 14,773 shares of the company's stock valued at $1,649,000 after purchasing an additional 2,372 shares in the last quarter. 86.65% of the stock is currently owned by institutional investors and hedge funds.

Revvity Trading Up 3.3%

RVTY stock traded up $2.91 during midday trading on Wednesday, hitting $90.91. 1,610,308 shares of the company's stock were exchanged, compared to its average volume of 1,611,554. Revvity Inc. has a one year low of $85.12 and a one year high of $129.50. The company has a debt-to-equity ratio of 0.43, a quick ratio of 2.75 and a current ratio of 3.33. The company has a market cap of $10.55 billion, a PE ratio of 38.52, a price-to-earnings-growth ratio of 2.36 and a beta of 0.91. The stock's fifty day moving average price is $94.98 and its 200-day moving average price is $100.68.

Revvity (NYSE:RVTY - Get Free Report) last issued its quarterly earnings data on Monday, July 28th. The company reported $1.18 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.14 by $0.04. The company had revenue of $720.28 million during the quarter, compared to the consensus estimate of $711.26 million. Revvity had a net margin of 10.19% and a return on equity of 7.66%. The firm's revenue was up 4.1% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.22 earnings per share. Research analysts predict that Revvity Inc. will post 4.94 earnings per share for the current fiscal year.

Revvity Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, November 7th. Shareholders of record on Friday, October 17th will be given a dividend of $0.07 per share. The ex-dividend date of this dividend is Friday, October 17th. This represents a $0.28 dividend on an annualized basis and a yield of 0.3%. Revvity's dividend payout ratio is 11.86%.

Analyst Ratings Changes

A number of research analysts recently issued reports on RVTY shares. Wells Fargo & Company reduced their price target on shares of Revvity from $130.00 to $102.00 and set an "equal weight" rating on the stock in a research report on Thursday, April 17th. Bank of America dropped their target price on shares of Revvity from $116.00 to $110.00 and set a "buy" rating for the company in a research note on Thursday, June 26th. UBS Group raised shares of Revvity from a "neutral" rating to a "buy" rating and decreased their price target for the company from $145.00 to $115.00 in a research note on Thursday, May 1st. JPMorgan Chase & Co. lowered their price target on shares of Revvity from $120.00 to $100.00 and set a "neutral" rating for the company in a report on Tuesday, April 29th. Finally, Stifel Nicolaus reduced their price objective on Revvity from $120.00 to $110.00 and set a "hold" rating on the stock in a report on Tuesday, July 29th. Five analysts have rated the stock with a hold rating and ten have issued a buy rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $120.07.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.